{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:16:11Z","timestamp":1778667371958,"version":"3.51.4"},"reference-count":75,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.molmed.2012.07.008","type":"journal-article","created":{"date-parts":[[2012,8,30]],"date-time":"2012-08-30T16:11:22Z","timestamp":1346343082000},"page":"607-614","source":"Crossref","is-referenced-by-count":24,"title":["Lipidated promiscuous peptides vaccine for tuberculosis-endemic regions"],"prefix":"10.1016","volume":"18","author":[{"given":"Uthaman","family":"Gowthaman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep K.","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nargis","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javed N.","family":"Agrewala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2012.07.008_bib0005","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/S0140-6736(10)60393-5","article-title":"New vaccines for tuberculosis","volume":"375","author":"Kaufmann","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2012.07.008_bib0010","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(10)60483-7","article-title":"Tuberculosis control and elimination 2010-50: cure, care, and social development","volume":"375","author":"Lonnroth","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2012.07.008_bib0015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.immuni.2010.09.015","article-title":"Future vaccination strategies against tuberculosis: thinking outside the box","volume":"33","author":"Kaufmann","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2012.07.008_bib0020","unstructured":"World Health Forum. (1993) Tuberculosis: a global emergency. World Health Forum 14, 438"},{"key":"10.1016\/j.molmed.2012.07.008_bib0025","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1126\/science.1184784","article-title":"Tuberculosis: what we don\u2019t know can, and does, hurt us","volume":"328","author":"Russell","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.molmed.2012.07.008_bib0030","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(10)60410-2","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis","volume":"375","author":"Gandhi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2012.07.008_bib0035","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/infdis\/jir548","article-title":"Promiscuous peptide of 16 kDa antigen linked to Pam2Cys protects against Mycobacterium tuberculosis by evoking enduring memory T cell response","volume":"204","author":"Gowthaman","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molmed.2012.07.008_bib0040","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro1211","article-title":"The success and failure of BCG \u2013 implications for a novel tuberculosis vaccine","volume":"3","author":"Andersen","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0045","first-page":"119","article-title":"Influence of sex, age & nontuberculous infection at intake on the efficacy of BCG: re-analysis of 15-year data from a double-blind randomized control trial in South India","volume":"123","author":"Narayanan","year":"2006","journal-title":"Ind. J. Med. Res."},{"key":"10.1016\/j.molmed.2012.07.008_bib0050","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.vaccine.2005.01.069","article-title":"Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?","volume":"23","author":"Rook","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.molmed.2012.07.008_bib0055","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1016\/j.vaccine.2011.05.023","article-title":"Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial","volume":"29","author":"Barreto","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.molmed.2012.07.008_bib0060","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1086\/314072","article-title":"Preventing tuberculosis with bacillus Calmette\u2013Guerin vaccine: a meta-analysis of the literature","volume":"3","author":"Brewer","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2012.07.008_bib0065","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(05)67534-4","article-title":"Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study","volume":"366","author":"Soysal","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2012.07.008_bib0070","first-page":"153","article-title":"What has Karonga taught us? Tuberculosis studied over three decades","volume":"13","author":"Crampin","year":"2009","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.molmed.2012.07.008_bib0075","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2249.2006.03222.x","article-title":"The influence of previous exposure to environmental mycobacteria on the interferon-\u03b3 response to Bacille Calmette\u2013Guerin vaccination in southern England and northern Malawi","volume":"146","author":"Weir","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0080","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tube.2010.06.002","article-title":"The Achilles heel of BCG","volume":"90","author":"Orme","year":"2010","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.molmed.2012.07.008_bib0085","first-page":"200","article-title":"Does the efficacy of BCG decline with time since vaccination?","volume":"2","author":"Sterne","year":"1998","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.molmed.2012.07.008_bib0090","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study","volume":"291","author":"Aronson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.molmed.2012.07.008_bib0095","doi-asserted-by":"crossref","first-page":"e2833","DOI":"10.1371\/journal.pone.0002833","article-title":"Effect of attenuation of Treg during BCG immunization on anti-mycobacterial Th1 responses and protection against Mycobacterium tuberculosis","volume":"3","author":"Jaron","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2012.07.008_bib0100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2567.2007.02575.x","article-title":"BCG stimulated dendritic cells induce an interleukin-10 producing T cell population with no T helper 1 or T helper 2 bias in vitro","volume":"121","author":"Madura Larsen","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.molmed.2012.07.008_bib0105","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.1128\/AEM.70.12.7571-7573.2004","article-title":"Diversity of nontuberculoid Mycobacterium species in biofilms of urban and semiurban drinking water distribution systems","volume":"70","author":"September","year":"2004","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0110","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1371\/journal.pntd.0000615","article-title":"Non-tuberculous mycobacteria in TB-endemic countries: are we neglecting the danger?","volume":"4","author":"Gopinath","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molmed.2012.07.008_bib0115","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/AEM.60.6.2180-2183.1994","article-title":"Isolation and identification of environmental mycobacteria in the Mycobacterium bovis BCG trial area of South India","volume":"60","author":"Kamala","year":"1994","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0120","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/322042","article-title":"Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi","volume":"184","author":"Black","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molmed.2012.07.008_bib0125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tube.2006.01.018","article-title":"Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not","volume":"86","author":"Rook","year":"2006","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.molmed.2012.07.008_bib0130","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","article-title":"BCG-induced increase in interferon-\u03b3 response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies","volume":"359","author":"Black","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2012.07.008_bib0135","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1128\/IAI.01826-06","article-title":"Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination","volume":"75","author":"Young","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molmed.2012.07.008_bib0140","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molmed.2012.07.008_bib0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-3083.1997.d01-99.x","article-title":"Crossreactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group","volume":"46","author":"Lozes","year":"1997","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0150","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.4049\/jimmunol.163.5.2688","article-title":"Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette\u2013Guerin involves class II transactivator and depends on the Nramp1 gene","volume":"163","author":"Wojciechowski","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0155","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.8098550","article-title":"Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages","volume":"260","author":"Pancholi","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.molmed.2012.07.008_bib0160","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.175.8.5324","article-title":"Mycobacterium bovis BCG attenuates surface expression of mature class II molecules through IL-10-dependent inhibition of cathepsin S","volume":"175","author":"Sendide","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0165","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.4049\/jimmunol.165.11.6073","article-title":"Interaction of Mycobacterium avium-containing phagosomes with the antigen presentation pathway","volume":"165","author":"Ullrich","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0170","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00281-003-0148-9","article-title":"Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders","volume":"25","author":"Rook","year":"2004","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0175","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.4049\/jimmunol.162.11.6843","article-title":"Helminth- and Bacillus Calmette\u2013Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis","volume":"162","author":"Malhotra","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2249.2001.01446.x","article-title":"Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette\u2013Guerin (BCG) vaccination","volume":"123","author":"Elias","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0185","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.vaccine.2004.09.038","article-title":"Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis","volume":"23","author":"Elias","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.molmed.2012.07.008_bib0190","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.4049\/jimmunol.151.9.4857","article-title":"Modulation of murine cytokine responses to mycobacterial antigens by helminth-induced T helper 2 cell responses","volume":"151","author":"Pearlman","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0195","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/IAI.00517-06","article-title":"Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis","volume":"74","author":"Santosuosso","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molmed.2012.07.008_bib0200","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nm.1991","article-title":"Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans","volume":"15","author":"O\u2019Brien","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2012.07.008_bib0205","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2012.07.008_bib0210","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.4049\/jimmunol.1100486","article-title":"Soluble proteins induce strong CD8+ T cell and antibody responses through electrostatic association with simple cationic or anionic lipopeptides that target TLR2","volume":"187","author":"Chua","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0215","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-59745-419-3_14","article-title":"Synthesis of toll-like receptor-2 targeting lipopeptides as self-adjuvanting vaccines","volume":"494","author":"Chua","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0220","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.vaccine.2006.07.012","article-title":"Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups","volume":"25","author":"Chua","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.molmed.2012.07.008_bib0225","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/eji.200535217","article-title":"Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza","volume":"36","author":"Deliyannis","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0230","doi-asserted-by":"crossref","first-page":"15440","DOI":"10.1073\/pnas.0406740101","article-title":"A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses","volume":"101","author":"Jackson","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2012.07.008_bib0235","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1365-2893.2008.01003.x","article-title":"Human dendritic cells pulsed with specific lipopeptides stimulate autologous antigen-specific T cells without the addition of exogenous maturation factors","volume":"15","author":"Jones","year":"2008","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.molmed.2012.07.008_bib0240","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/icb.2010.15","article-title":"A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody","volume":"88","author":"Pejoski","year":"2010","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0245","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.icb.7100021","article-title":"Induction of neutralizing antibody responses to hepatitis C virus with synthetic peptide constructs incorporating both antibody and T-helper epitopes","volume":"85","author":"Torresi","year":"2007","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0250","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/hep.21538","article-title":"A self-adjuvanting multiepitope immunogen that induces a broadly crossreactive antibody to hepatitis C virus","volume":"45","author":"Torresi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2012.07.008_bib0255","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1016\/j.vaccine.2005.04.015","article-title":"Characterisation of the antibody response to a totally synthetic immunocontraceptive peptide vaccine based on LHRH","volume":"23","author":"Zeng","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.molmed.2012.07.008_bib0260","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.molimm.2010.10.003","article-title":"Lipidation of intact proteins produces highly immunogenic vaccine candidates","volume":"48","author":"Zeng","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0265","doi-asserted-by":"crossref","first-page":"12944","DOI":"10.1074\/jbc.M111.227744","article-title":"A modular approach to assembly of totally synthetic self-adjuvanting lipopeptide-based vaccines allows conformational epitope building","volume":"286","author":"Zeng","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2012.07.008_bib0270","doi-asserted-by":"crossref","first-page":"15050","DOI":"10.1073\/pnas.96.26.15050","article-title":"Abundant empty class II MHC molecules on the surface of immature dendritic cells","volume":"96","author":"Santambrogio","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2012.07.008_bib0275","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1073\/pnas.81.8.2489","article-title":"Processing of lysozyme by macrophages: identification of the determinant recognized by two T cell hybridomas","volume":"81","author":"Allen","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2012.07.008_bib0280","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0285","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1126\/science.285.5428.732","article-title":"Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors","volume":"285","author":"Brightbill","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.molmed.2012.07.008_bib0290","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF03402131","volume":"9","author":"Iwai","year":"2003","journal-title":"Mol. Med."},{"key":"10.1016\/j.molmed.2012.07.008_bib0295","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1053\/j.gastro.2008.02.058","article-title":"Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41","volume":"134","author":"Klade","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2012.07.008_bib0300","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1586\/epr.09.71","article-title":"In silico methods for predicting T cell epitopes: Dr Jekyll or Mr Hyde?","volume":"6","author":"Gowthaman","year":"2009","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.molmed.2012.07.008_bib0305","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","article-title":"Reverse vaccinology: developing vaccines in the era of genomics","volume":"33","author":"Sette","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2012.07.008_bib0310","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2172-13-13","article-title":"Potential T cell epitopes of Mycobacterium tuberculosis that can instigate molecular mimicry against host: implications in autoimmune pathogenesis","volume":"13","author":"Chodisetti","year":"2012","journal-title":"BMC Immunol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0315","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/CMR.13.3.470-511.2000","article-title":"Pathogenesis of group A streptococcal infections","volume":"13","author":"Cunningham","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.molmed.2012.07.008_bib0320","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/74719","article-title":"New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population","volume":"6","author":"Brandt","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2012.07.008_bib0325","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/505146","article-title":"Intranasal vaccination with a lipopeptide containing a conformationally constrained conserved minimal peptide, a universal T cell epitope, and a self-adjuvanting lipid protects mice from group A streptococcus challenge and reduces throat colonization","volume":"194","author":"Batzloff","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molmed.2012.07.008_bib0330","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1389450024605436","article-title":"The central role played by peptides in the immune response and the design of peptide-based vaccines against infectious diseases and cancer","volume":"3","author":"Jackson","year":"2002","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.molmed.2012.07.008_bib0335","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrd2224","article-title":"More than one reason to rethink the use of peptides in vaccine design","volume":"6","author":"Purcell","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2012.07.008_bib0340","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa0810097","article-title":"Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia","volume":"361","author":"Kenter","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2012.07.008_bib0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humimm.2011.10.006","article-title":"Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-\u03b3 and reduces parasite burden in HLA-B*0702 mice","volume":"73","author":"Cong","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0350","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1084\/jem.20051782","article-title":"TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis","volume":"202","author":"Bafica","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2012.07.008_bib0355","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.4049\/jimmunol.169.7.3480","article-title":"Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis","volume":"169","author":"Reiling","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0360","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-2002-20088","article-title":"Induction of direct antimicrobial activity through mammalian toll-like receptors","volume":"56","author":"Stenger","year":"2002","journal-title":"Pneumologie"},{"key":"10.1016\/j.molmed.2012.07.008_bib0365","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.molmed.2012.07.008_bib0370","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.4049\/jimmunol.0901683","article-title":"TLR2 engagement on dendritic cells promotes high frequency effector and memory CD4 T cell responses","volume":"183","author":"Chandran","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2012.07.008_bib0375","first-page":"218590","article-title":"Emerging vaccine informatics","volume":"2010","author":"He","year":"2010","journal-title":"J. Biomed. Biotechnol."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149141200144X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149141200144X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T13:46:21Z","timestamp":1687700781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149141200144X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":75,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S147149141200144X"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2012.07.008","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}